查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1923885

醫用聚氨酯市場按應用、類型、形式和最終用戶分類－2026年至2032年全球預測

Medical Polyurethane Market by Application, Type, Form, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫用聚氨酯市場規模將達到 28.5 億美元，到 2026 年將成長至 31.1 億美元，到 2032 年將達到 56.4 億美元，複合年成長率為 10.23%。

關鍵市場統計數據
基準年 2025 28.5億美元
預計年份：2026年 31.1億美元
預測年份 2032 56.4億美元
複合年成長率 (%) 10.23%

簡要概述聚合物化學和加工技術的進步如何與臨床要求相結合，從而重新定義醫療設備的設計可能性。

醫用級聚氨酯材料憑藉其可調的機械性能和成熟的生物相容性，正在革新各種臨床應用領域的醫療設備設計。近年來，材料化學和加工技術的進步使得更薄的薄膜、更柔軟的彈性體以及更可靠的長期植入成為可能，同時也能保持其耐滅菌性能。因此，產品設計人員能夠滿足更廣泛的患者需求，從需要抗彎曲性能的軟性導管到需要抗疲勞耐久性的承重假體關節組件。

識別正在重塑醫用聚氨酯行業的當代趨勢，這些趨勢體現在材料創新、監管生命週期要求和供應鏈韌性的交匯點上。

醫用聚氨酯產業正經歷一系列變革，其驅動力包括材料科學的創新、臨床通訊協定的不斷改進以及患者對個人化治療日益成長的需求。先進的配方技術正在最佳化彈性體性能和抗疲勞性能，從而實現更小的醫療器材尺寸和更高的患者舒適度。同時，積層製造和精密擠出技術能夠實現更複雜的幾何形狀和更快的原型製作週期，縮短從設計到臨床評估的時間。

關稅驅動的採購壓力正推動策略性供應鏈重組和營運投資，以保障醫療設備生產的連續性。

影響進口關稅和關稅表的政策變化正在影響整個供應鏈的策略採購決策和資本投資模式。在相關政策週期內實施的關稅調整提高了原料採購的成本敏感性，促使採購團隊重新評估其供應商組合，並考慮近岸外包和區域內加工方案，以降低到岸成本波動和交貨日期不確定性。

基於策略性細分的洞察，將材料化學、加工方式和終端用戶期望相結合，能夠加速臨床應用並實現產品差異化。

對市場區隔的深入了解揭示了技術研發和商業化工作的重點領域。按應用領域分類，目標領域包括循環系統（如心臟瓣膜、支架和血管移植物）、薄膜和片材、整形外科和假體器械、導管和管材以及創傷護理敷料。每種應用對柔軟性、耐滅菌性和生物穩定性都有不同的要求，這些要求決定了配方設計和加工方法的選擇。依類型分類，聚氨酯分為熱塑性聚氨酯和熱固性聚氨酯。熱塑性樹脂通常具有可回收加工性和易於擠出的優點，而熱固性系統則透過形成交聯網路來增強高溫穩定性和長期機械完整性。按形狀分類，產品供應形式包括薄膜和片材、液態樹脂、粉末和棒材，這些形式決定了合適的製造程序，例如浸塑成型、擠出成型、澆鑄成型和機械加工。按最終用戶分類，主要供應目的地包括門診手術中心、居家醫療和醫院。每個終端使用者群體對產品屬性的重視程度不同，例如一次性使用、易於操作和長期植入可靠性。

深入了解區域趨勢和策略定位，繪製全球主要醫療保健叢集的臨床需求概況和製造地

區域趨勢正在塑造投資趨勢和市場機遇，每個地理叢集都反映了不同的法規環境、製造能力和臨床應用模式。在美洲，手術量和完善的報銷機制推動了對先進導管和管路解決方案的集中需求，從而促進了對本土配製和器械整合的投資。在歐洲、中東和非洲，部分市場的監管協調工作和新興醫療基礎設施正在推動對多功能薄膜和片材解決方案以及能夠滿足廣泛臨床需求的成本效益型生產模式的興趣。在亞太地區，外科手術能力的快速擴張、居家醫療服務的成長以及蓬勃發展的聚合物加工生態系統，正在為本地製造和合作產品開發創造動力。

關鍵的競爭考察表明，材料創新、監管合規經驗和整合製造如何在醫用聚氨酯領域創造永續的差異化優勢。

醫用聚氨酯的競爭優勢在於材料專業知識、垂直整合的生產模式、監管能力以及與醫療設備製造商 (OEM) 的合作開發。領先的材料專家投資於專有的化學技術，以實現客製化的彈性體性能和增強的滅菌相容性；而提供從混煉到最終成型的端到端服務的加工商則透過降低 OEM 認證流程的複雜性來創造價值。聚合物製造商與臨床創新者之間的策略聯盟，透過將材料開發與手術需求和療效指標結合，加速了轉化研究進程。

加強供應鏈韌性、加速監管合規性以及使材料創新與臨床證據產生一致的實用建議

產業領導者應優先考慮平衡策略，在加速下一代材料臨床檢驗的同時，增強供應鏈韌性。首先，將供應商選擇與情境規劃結合，以降低單點故障風險，並在不影響生物相容性要求的前提下快速替換原料。其次，透過在早期開發階段納入可萃取物和可浸出物測試、滅菌相容性測試以及生命週期安全性評估，使研發藍圖與監管要求保持一致，從而減少返工並加快臨床評估進程。第三，投資於能夠處理多種規格產品的模組化生產能力，包括薄膜、液態樹脂和擠出管材，以最佳化生產效率並減輕多條產品線的認證負擔。

一個穩健的多學科研究框架，結合相關人員訪談、材料評估和供應鏈圖譜分析，能夠提供切實可行的見解和檢驗的建議。

我們的研究途徑結合了定性和定量資訊收集、材料評估和法規分析，以確保獲得全面的觀點。主要研究包括對材料科學家、醫療設備工程師、採購主管和法規專家進行結構化訪談，以了解營運實務和策略意圖。次要研究包括查閱公開的法規指南、標準文獻和技術出版物，以檢驗關鍵應用的測試要求和滅菌限制。

本文全面探討了材料創新、日益嚴格的法規和策略性供應鏈規劃將如何共同決定醫用聚氨酯應用領域的未來領導地位。

總而言之，醫用聚氨酯在各種臨床環境中發揮核心作用，協助打造更安全、更舒適、更可靠的醫療設備。材料技術的進步正在催生新的器材架構，而不斷完善的法規也正在建立規範，從而提升臨床療效聲明的可信度。同時，成本波動和關稅變化等外部壓力正在加速採購和生產地點的策略性轉變，迫使各組織重新思考籌資策略和產能策略。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 醫用聚氨酯市場（依應用領域分類）

  • 心血管器械
    • 心臟瓣膜
    • 支架
    • 血管移植
  • 薄膜和片材
  • 整形外科和義肢設備
  • 導管和導尿管
  • 傷口敷料

9. 醫用聚氨酯市場（按類型分類）

  • 熱塑性聚氨酯
  • 熱固性聚氨酯

第10章 醫用聚氨酯市場（按類型分類）

  • 薄膜和片材
  • 液態樹脂
  • 粉末
  • 棒材

第11章 以最終用戶分類的醫用聚氨酯市場

  • 門診手術中心
  • 居家醫療
  • 醫院

第12章 區域性醫用聚氨酯市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 醫用聚氨酯市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國醫用聚氨酯市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國醫用聚氨酯市場

第16章：中國醫用聚氨酯市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Arkema SA
  • Avient Corporation
  • B. Braun SE
  • BASF SE
  • Bayer AG
  • Cardinal Health, Inc.
  • Covestro AG
  • Dow Inc.
  • DSM Engineering Materials
  • Evonik Industries AG
  • Huntsman Corporation
  • Lubrizol Corporation
  • Merck KGaA
  • Mitsui Chemicals, Inc.
  • PolyOne Corporation
  • Sanyo Chemical Industries, Ltd.
  • Sekisui Chemical Co., Ltd.
  • Stahl Holdings BV
  • Teleflex Incorporated
  • Wanhua Chemical Group Co., Ltd.
Product Code: MRR-7A380DA7C314

The Medical Polyurethane Market was valued at USD 2.85 billion in 2025 and is projected to grow to USD 3.11 billion in 2026, with a CAGR of 10.23%, reaching USD 5.64 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.85 billion
Estimated Year [2026] USD 3.11 billion
Forecast Year [2032] USD 5.64 billion
CAGR (%) 10.23%

A concise orientation to how advances in polymer chemistry and processing are converging with clinical requirements to redefine design possibilities for medical devices

Medical grade polyurethanes are reshaping device design across a range of clinical applications by combining tunable mechanical performance with proven biocompatibility. In recent years, material chemistries and processing techniques have matured to enable thinner films, softer elastomers, and more reliable long term implants while preserving sterilization resilience. As a result, product designers can now address a broader spectrum of patient needs, from flexible tubing and catheters that demand kink resistance to load bearing prosthetic components that require fatigue endurance.

Consequently, stakeholders across the value chain are reorienting product roadmaps around multifunctional performance rather than single attribute improvements. Regulatory expectations are rising in parallel, prompting developers to invest earlier in biocompatibility testing, extractables and leachables studies, and sterilization compatibility assessments. This convergence of material capability and regulatory rigor creates both opportunity and complexity: manufacturers that integrate application specific testing with scalable processing will capture clinical adoption advantages, while those that delay compliance integration will encounter costlier rework and market access delays.

Taken together, the introduction sets the stage for an executive level exploration of where clinical need, polymer innovation, and regulatory pathways intersect, and it frames why strategic decisions made today will determine competitive positioning in the near to medium term.

Distilling the modern forces reshaping the medical polyurethane sector where material innovation meets regulatory lifecycle demands and supply chain resilience

The medical polyurethane landscape is experiencing a sequence of transformative shifts driven by innovation in material science, evolving clinical protocols, and growing expectations for personalized therapies. Advanced formulations are optimizing elastomeric behavior and fatigue resistance, enabling device miniaturization and enhanced patient comfort. Concurrently, additive manufacturing and precision extrusion methods are enabling more complex geometries and faster iteration cycles, which shortens design to clinical evaluation timelines.

At the same time, regulatory frameworks are moving toward lifecycle oriented oversight that emphasizes postmarket surveillance and real world evidence. This regulatory evolution incentivizes manufacturers to invest in robust traceability systems and in-device sensors that can produce outcome data. Meanwhile, supply chain resilience has become a strategic priority; manufacturers are diversifying sourcing and exploring regional processing hubs to reduce lead time variability and exposure to upstream disruptions. Together, these shifts are producing a market dynamic where material performance alone is insufficient; success requires integrated strategies that combine material engineering, regulatory foresight, and supply chain agility.

Therefore, organizations that adopt cross functional collaboration between R&D, regulatory, and operations teams will be best positioned to capitalize on these shifts, accelerate product introductions, and sustain clinical trust.

How tariff driven procurement pressures are prompting strategic supply chain realignments and operational investments to protect device production continuity

Policy changes affecting import duties and tariff schedules are influencing strategic sourcing decisions and capital investment patterns across the supply chain. Tariff adjustments implemented in the referenced policy cycle have increased the cost sensitivity of raw material procurement, prompting procurement teams to reassess supplier portfolios and to evaluate nearshoring and regional processing options to mitigate landed cost volatility and delivery uncertainty.

In response, many manufacturers have accelerated qualification of alternative feedstocks and adopted longer term agreements with regional processors to stabilize input availability. This, in turn, has influenced inventory strategies, with firms opting for more conservative safety stocks and closer integration with contract manufacturers to preserve production continuity. Operationally, some device makers have redirected capital toward domestic compounding and conversion capacity to reduce exposure to cross border duties and to preserve margin.

While tariffs have created short term pressure on cost structures, they have also catalyzed efficiency initiatives and strategic partnerships that reduce dependence on single source geographies. Over time, these adaptations are likely to strengthen resilience and foster closer collaboration between polymer producers and device OEMs, resulting in more predictable supply flows and improved alignment between material specifications and clinical performance requirements.

Strategic segmentation oriented insights that align material chemistry, processing formats, and end user expectations to accelerate clinical adoption and product differentiation

A granular understanding of market segmentation reveals where technical focus and commercialization efforts should be concentrated. Based on Application, the landscape encompasses Cardiovascular Devices including Heart Valves, Stents, and Vascular Grafts, as well as Films and Sheets, Orthopedic and Prosthetic Devices, Tubing and Catheters, and Wound Care Dressings; each application imposes distinct requirements for flexibility, sterilization tolerance, and biostability, which drives formulation and processing choices. Based on Type, the sector divides into Thermoplastic Polyurethane and Thermoset Polyurethane; thermoplastics generally offer recyclable processing and ease of extrusion while thermoset systems provide crosslinked networks that enhance high temperature stability and long term mechanical integrity. Based on Form, product delivery formats encompass Films and Sheets, Liquid Resin, Powder, and Rod, and these forms determine compatible manufacturing routes such as dip molding, extrusion, casting, or machining. Based on End User, the primary delivery channels include Ambulatory Surgical Centers, Homecare, and Hospitals, and each end user segment emphasizes different product attributes such as disposability, ease of handling, or long term implant reliability.

Consequently, commercialization and R&D roadmaps must be tailored to these segmentation nuances. For example, cardiovascular implant materials require exhaustive biocompatibility and fatigue testing and close collaboration with clinicians for in vivo performance validation, whereas materials intended for homecare dressings prioritize cost effective sterilization and user safety. By aligning material selection, processing capability, and regulatory strategy with these segment specific criteria, organizations can accelerate acceptance and reduce iteration cycles during clinical validation.

Regional dynamics and strategic positioning insights that map clinical demand profiles and manufacturing footprints across major global healthcare clusters

Regional dynamics are shaping investment flows and market opportunities, with each geographic cluster reflecting different regulatory environments, manufacturing capabilities, and clinical adoption patterns. In the Americas, there is concentrated demand for advanced catheter and tubing solutions driven by procedural volumes and established reimbursement frameworks, which supports investments in domestic compounding and device integration. In Europe, Middle East and Africa, regulatory harmonization efforts and emerging medical infrastructure in select markets are stimulating interest in versatile film and sheet solutions and in cost effective production models that can serve a broad clinical base. In Asia Pacific, rapid expansion of surgical capacity, growth in homecare services, and an active ecosystem of polymer converters are creating momentum for localized manufacturing and collaborative product development.

These regional patterns are influencing where companies choose to site processing capacity, where they prioritize regulatory submissions, and how they structure distribution networks. Cross regional partnerships and licensing models are increasingly common as firms seek to leverage local clinical expertise while maintaining centralized quality control. Therefore, a regionalized strategy that considers clinical needs, regulatory pathways, and manufacturing footprint will be essential for organizations aiming to scale sustainably across multiple territories.

Critical competitive insights showing how material innovation, regulatory track record, and integrated manufacturing create sustainable differentiation in the medical polyurethane arena

Competitive positioning in medical polyurethane is centered on a combination of material expertise, vertically integrated manufacturing, regulatory competency, and collaborative development with medical device OEMs. Leading material specialists invest in proprietary chemistries that deliver tailored elastomeric behavior and enhanced sterilization compatibility, while converters that offer end to end services from compounding through final forming add value by reducing qualification complexity for OEMs. Strategic alliances between polymer manufacturers and clinical innovators accelerate translational pathways by aligning material development with procedural needs and outcome measures.

Moreover, companies differentiating on quality management and regulatory track record command preferential consideration from device makers that require predictable supply and documentation for clinical submissions. Innovation in additive manufacturing and continuous processing is creating new entrants that combine agile prototyping with focused clinical validation, challenging incumbents to adapt or partner. In parallel, value chain consolidation through selective acquisitions and capacity investments is reshaping competitive dynamics, as firms seek to control critical steps of the conversion process to protect margins and ensure compliance.

Taken together, the competitive field rewards organizations that marry deep polymer science with manufacturing scale and regulatory excellence, and those that can demonstrate verified clinical performance through rigorous testing and real world evidence collection.

Action oriented recommendations to enhance supply chain resilience, accelerate regulatory readiness, and align material innovation with clinical evidence generation

Industry leaders should prioritize a balanced strategy that strengthens supply chain resilience while accelerating clinical validation of next generation materials. First, integrate supplier qualification with scenario planning to reduce single point of failure exposure and to enable rapid substitution of feedstocks without compromising biocompatibility requirements. Second, align R&D roadmaps with regulatory expectations by embedding extractables and leachables testing, sterilization compatibility studies, and lifecycle safety assessments into early stage development to reduce rework and shorten time to clinical evaluation. Third, invest in modular manufacturing capabilities that can scale across forms such as films, liquid resins, and extruded tubing to optimize throughput and reduce qualification burdens for multiple product families.

In addition, pursue collaborative partnerships with device OEMs and clinical research groups to co-develop application specific solutions that deliver validated clinical benefits and generate outcome data. Establishing robust postmarket surveillance and data capture mechanisms will not only meet regulatory imperatives but will also create commercial differentiation through evidence based claims. Finally, evaluate regional processing options and consider escalating nearshore capacity where tariffs and logistics create cost pressure, thereby preserving margin and reducing lead time variability. By implementing these measures, organizations can convert current market pressures into long term competitive advantage.

A robust multi method research framework combining stakeholder interviews, materials evaluation, and supply chain mapping to deliver actionable insights and validated recommendations

The research approach combines qualitative and quantitative intelligence gathering with materials evaluation and regulatory analysis to ensure a holistic perspective. Primary research consisted of structured interviews with material scientists, device engineers, procurement leaders, and regulatory specialists to capture operational realities and strategic intent. Secondary research reviewed publicly available regulatory guidances, standards literature, and technical publications to validate testing requirements and sterilization constraints across key applications.

Technical validation incorporated comparative review of polymer performance characteristics across thermoplastic and thermoset systems, and examined manufacturing method compatibility for different forms including films, resins, powders, and rods. Supply chain mapping identified critical nodes and potential single source exposures, while scenario analysis assessed the operational implications of tariff regimes and regional capacity shifts. Finally, findings were synthesized through cross functional triangulation to ensure that conclusions reflect consistent patterns across clinical needs, material performance, and commercial strategy.

This multi method design ensures that recommendations are grounded in both practical operational considerations and in the technical realities of material behavior and regulatory expectations.

A concluding synthesis of how material innovation, regulatory rigor, and strategic supply planning jointly determine future leadership in medical polyurethane applications

In summary, medical polyurethanes occupy a central role in enabling safer, more comfortable, and more reliable medical devices across a broad range of clinical contexts. Material advances are unlocking new device architectures, and regulatory evolution is instilling a discipline that strengthens the credibility of clinical claims. At the same time, external pressures such as cost volatility and tariff changes are accelerating strategic shifts in sourcing and production footprints, prompting organizations to rethink procurement and capacity strategies.

Consequently, success in this market will depend on an integrated approach that combines material innovation with regulatory foresight, manufacturing flexibility, and collaborative clinical validation. Firms that align technical development with evidence generation and that build resilient, regionally informed supply models will be positioned to lead. Conversely, organizations that treat materials as interchangeable commodities risk slower adoption and greater exposure to compliance setbacks.

The conclusion reinforces that deliberate investment in testing, partnerships, and processing capability will convert current market complexity into long term strategic advantage and sustained clinical impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Polyurethane Market, by Application

  • 8.1. Cardiovascular Devices
    • 8.1.1. Heart Valves
    • 8.1.2. Stents
    • 8.1.3. Vascular Grafts
  • 8.2. Films & Sheets
  • 8.3. Orthopedic & Prosthetic Devices
  • 8.4. Tubing & Catheters
  • 8.5. Wound Care Dressings

9. Medical Polyurethane Market, by Type

  • 9.1. Thermoplastic Polyurethane
  • 9.2. Thermoset Polyurethane

10. Medical Polyurethane Market, by Form

  • 10.1. Films & Sheets
  • 10.2. Liquid Resin
  • 10.3. Powder
  • 10.4. Rod

11. Medical Polyurethane Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Homecare
  • 11.3. Hospitals

12. Medical Polyurethane Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Medical Polyurethane Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Medical Polyurethane Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Medical Polyurethane Market

16. China Medical Polyurethane Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Arkema S.A.
  • 17.6. Avient Corporation
  • 17.7. B. Braun SE
  • 17.8. BASF SE
  • 17.9. Bayer AG
  • 17.10. Cardinal Health, Inc.
  • 17.11. Covestro AG
  • 17.12. Dow Inc.
  • 17.13. DSM Engineering Materials
  • 17.14. Evonik Industries AG
  • 17.15. Huntsman Corporation
  • 17.16. Lubrizol Corporation
  • 17.17. Merck KGaA
  • 17.18. Mitsui Chemicals, Inc.
  • 17.19. PolyOne Corporation
  • 17.20. Sanyo Chemical Industries, Ltd.
  • 17.21. Sekisui Chemical Co., Ltd.
  • 17.22. Stahl Holdings B.V.
  • 17.23. Teleflex Incorporated
  • 17.24. Wanhua Chemical Group Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL POLYURETHANE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL POLYURETHANE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MEDICAL POLYURETHANE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MEDICAL POLYURETHANE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY HEART VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY HEART VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY FILMS & SHEETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY FILMS & SHEETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY FILMS & SHEETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY ORTHOPEDIC & PROSTHETIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY ORTHOPEDIC & PROSTHETIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY ORTHOPEDIC & PROSTHETIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY TUBING & CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY TUBING & CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY TUBING & CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY WOUND CARE DRESSINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY WOUND CARE DRESSINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY WOUND CARE DRESSINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY THERMOPLASTIC POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY THERMOPLASTIC POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY THERMOPLASTIC POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY THERMOSET POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY THERMOSET POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY THERMOSET POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY FILMS & SHEETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY FILMS & SHEETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY FILMS & SHEETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY LIQUID RESIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY LIQUID RESIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY LIQUID RESIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY ROD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY ROD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY ROD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY HOMECARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS MEDICAL POLYURETHANE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. GCC MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GCC MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. GCC MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 117. GCC MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. GCC MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 119. GCC MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. G7 MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. G7 MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. G7 MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 135. G7 MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. G7 MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 137. G7 MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. NATO MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. NATO MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. NATO MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 141. NATO MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. NATO MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 143. NATO MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES MEDICAL POLYURETHANE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA MEDICAL POLYURETHANE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 154. CHINA MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)